Pharma companies admit to sharing 'sensitive' info to keep prices high

U.S. prosecutors are pressing a massive case for alleged generic drug price fixing against the industry's top players. Now, U.K. antitrust authorities have found a case of two rivals sharing "commercially sensitive" information.